Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient

被引：0
|
作者：
Orlova, V. V. [1 ]
Cao, X. [1 ]
Freund, C. [1 ]
Sanchez-Duffhues, G. [2 ]
Hawinkels, L. [3 ]
Petrus-Reurer, S. [1 ]
van den Hil, F. E. [1 ]
Disch, F. [4 ]
Snijder, R. J. [4 ]
Westermann, C. J. J. [4 ]
Mager, J. J. [4 ]
ten Dijke, P. [2 ]
van Amstel, Ploos J. K. [5 ]
Mummery, C. L. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Gastroenterol Hepatol, Leiden, Netherlands
[4] St Antonius Hosp, Nieuwegein, Netherlands
[5] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
来源：
ANGIOGENESIS | 2018年 / 21卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14
    Letteboer, Tom G. W.
    Benzinou, Michael
    Merrick, Christopher B.
    Quigley, David A.
    Zhau, Kechen
    Kim, Il-Jin
    To, Minh D.
    Jablons, David M.
    van Amstel, Johannes K. P.
    Westermann, Cornelius J. J.
    Giraud, Sophie
    Dupuis-Girod, Sophie
    Lesca, Gaetan
    Berg, Jonathan H.
    Balmain, Allan
    Akhurst, Rosemary J.
    FRONTIERS IN GENETICS, 2015, 6
  • [32] Development of novel treatment strategies for SGCE dystonia using patient-derived induced pluripotent stem cells (iPSCs)
    Staege, S.
    Kutschenko, A.
    Seibler, P.
    Grutz, K.
    Hermann, A.
    Wegner, F.
    MOVEMENT DISORDERS, 2020, 35 : S56 - S56
  • [33] Modeling Genetic Dilated Cardiomyopathies With Engineered Heart Tissues From Patient-derived And Isogenic Mutant Induced Pluripotent Stem Cells
    Tsui, Jonathan H.
    Zepeda, Bernardo
    Steltzer, Stephanie S.
    Ho, Jaclyn J.
    Priest, James
    Hoey, Timothy
    CIRCULATION RESEARCH, 2022, 131
  • [34] LNGFR (+) THY-1 (+) multipotent stem cells derived from human induced pluripotent stem cells
    Ouchi, Takehito
    Shibata, Shinsuke
    Kimura, Hiroo
    Nagoshi, Narihito
    Fujimura, Takumi
    Morikawa, Satoru
    Sato, Kazuki
    Kawana, Hiromasa
    Fukuda, Kimiko
    Nakamura, Masaya
    Nakagawa, Taneaki
    Okano, Hideyuki
    MECHANISMS OF DEVELOPMENT, 2017, 145 : S169 - S170
  • [35] RETRACTION: Establishment of a human induced pluripotent stem cell line, KMUGMCi001-A, from a patient bearing a heterozygous c.772+3_772+4dup mutation in the ACVRL1 gene leading Telangiectasia, hereditary hemorrhagic, type 2 (HHT2)
    Ura, Hiroki
    Togi, Sumihito
    Iwata, Yumiko
    Ozaki, Mamoru
    Niida, Yo
    STEM CELL RESEARCH, 2022, 61
  • [36] Role of microRNA-1a (miR-1a) in the Differentiation of Induced Pluripotent Stem Cells (iPSCs) to Endothelial Cells (ECs)
    Liang, Jialiang
    Huang, Wei
    Wang, Yuhua
    Kang, Kai
    Wen, Zili
    Ashraf, Atif
    Millard, Ronald W.
    Xu, Meifeng
    Ashraf, Muhammad
    Wang, Yigang
    CIRCULATION, 2012, 126 (21)
  • [37] GENERATION OF MONOCYTES, MACROPHAGES AND DENDRITIC CELLS FROM NORMAL AND BCR-ABL-EXPRESSING PATIENT-DERIVED INDUCED PLURIPOTENT STEM CELLS (IPSCS)
    Vera, K.
    Imeri, J.
    Marcoux, P.
    Desterke, C.
    Sujariyakul, P.
    Huygue, M.
    Latsis, T.
    Griscelli, A. Bennaceur
    Turhan, A. G.
    CYTOTHERAPY, 2023, 25 (06) : S282 - S282
  • [38] Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1
    Galaris, Georgios
    Montagne, Kevin
    Thalgott, Jeremy H.
    Goujon, Geoffroy J. P. E.
    van den Driesche, Sander
    Martin, Sabrina
    Mager, Hans-Jurgen J.
    Mummery, Christine L.
    Rabelink, Ton J.
    Lebrin, Franck
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [39] Thresholds of endoglin expression in endothelial cells explains vascular etiology in hereditary hemorrhagic telangiectasia type 1
    Thalgott, J. H.
    Montagne, K.
    Galaris, G.
    Goujon, G. P. E.
    Vd, Driesche S.
    Martin, S.
    Mager, H. J.
    Mummery, C. L.
    Rabelink, T. J.
    Lebrin, F.
    ANGIOGENESIS, 2023, 26 (01) : S12 - S12
  • [40] Induced Pluripotent Stem Cells (iPSCs) Derived from Different Cell Sources and their Potential for Regenerative and Personalized Medicine
    Shtrichman, R.
    Germanguz, I.
    Itskovitz-Eldor, J.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (05) : 792 - 805
12345